The Pharma Data

APRIL 26, 2022

director of the FDA’s Center for Drug Evaluation and Research. Today’s approval of the first COVID-19 therapeutic for this population demonstrates the agency’s commitment to that need.”. Learn more about FDA-approved and authorized COVID-19 vaccines. Today, the U.S.

FDA Approval 52

FDA Approval Vaccination Vaccine Cosmetics 52

The Pharma Data

NOVEMBER 21, 2021

Food and Drug Administration approved Voxzogo (vosoritide) injection to improve growth in children five years of age and older with achondroplasia and open epiphyses (growth plates), meaning these children still have the potential to grow. Today, the U.S. Achondroplasia is the most common form of dwarfism.

FDA Approval 52

FDA Approval Drugs Regulation Genetics 52

Camargo

NOVEMBER 15, 2021

FDA Guidance Addresses Real-World Evidence Data Standards. The 21 st Century Cures Act generated a good deal of excitement and interest when it added a section called “ Utilizing Real World Evidence ” to the Food, Drug, and Cosmetic Act (Section 505F). FDA Publishes ICH Guidelines on Continuous Manufacturing.

Development 187

Development Manufacturing Production Packaging 187

The Pharma Data

NOVEMBER 23, 2021

Approval is for Cytomegalovirus, a Type of Herpes Virus. director of the Office of Infectious Diseases in the FDA’s Center for Drug Evaluation and Research. Cytomegalovirus infections that are resistant or do not respond to available drugs are of even greater concern. Today, the U.S. Source link: [link].

FDA Approval 52

FDA Approval Drugs DNA Cosmetics 52

FDA Law Blog

AUGUST 21, 2023

Livornese — I saw the sign…and the answer is no—FDA-approved labeling apparently is not enough under state failure-to-warn laws, according to certain courts. Brand drugs, generic drugs, and medical devices alike have all been the target of state failure-to-warn litigation; in a recent case, OTC acetaminophen is the target.

FDA Approval 40

FDA Approval Production Drugs Generic Drugs 40

The Pharma Data

MARCH 15, 2022

Agency Supports Development of Complex Generic Drug-Device Combination Product to Improve Competition and Access to More Affordable Medicines. This complex generic drug-device combination product, which is a metered-dose inhaler, should not be used to treat acute asthma attacks. Today, the U.S.

FDA Approval 52

FDA Approval Generic Drugs Production Drugs 52

Camargo

DECEMBER 13, 2021

Both the FDA’s Center for Drug Evaluation and Research (CDER) and its Center for Biologics Evaluation and Research (CBER) have regulatory responsibility for therapeutic biological products, which are subject to both the Federal Food, Drug and Cosmetic (FD & C) Act and the Public Health Service (PHS) Act.

Development 161

Development Production Immune Response Licensing 161

The Pharma Data

FEBRUARY 24, 2022

Food and Drug Administration approved Jardiance (empagliflozin) to reduce the risk of cardiovascular death and hospitalization for heart failure in adults. Jardiance was originally approved by the FDA in 2014 as a supplement to diet and exercise to improve glucose control in adults with type 2 diabetes. Today, the U.S.

FDA Approval 52

FDA Approval Cardiology Cosmetics Production 52

FDA Law Blog

JANUARY 5, 2022

Sara’s practice covers the intersection of FDA regulatory issues and Intellectual Property, including the Hatch-Waxman Amendments, the Biologics Price Competition and Innovation Act, and the Orphan Drug Act, biosimilars, and the Orange Book. Sara joined the firm from a well-recognized intellectual property firm in 2017.

Cosmetics 52

Cosmetics FDA Approval Drugs Production 52

Advarra

JULY 26, 2022

with 37 states approving medicinal use and 18 approving recreationally. However, it’s not legal federally and is considered a Schedule I drug by the U.S. Drug Enforcement Administration (DEA), meaning it has no accepted medical use and a high potential for abuse. The FDA is granting INDs for such CBD research.

Regulation 97

Regulation Research Production Cosmetics 97

XTalks

MAY 25, 2023

In this episode, Vera talked about the US Food and Drug Administration’s (FDA) approval of Veozah (fezolinetant), the new type of drug for menopausal hot flashes and night sweats. The team discussed Veozah and the benefits of this drug for women’s health. during or after the menopausal transition.

Filler 52

Filler Life Science FDA Approval Drugs 52

The Pharma Data

NOVEMBER 12, 2021

Treatment is First FDA-Approved Option Patients Can Take Regardless of Previous Therapies. Food and Drug Administration approved Besremi (ropeginterferon alfa-2b-njft) injection to treat adults with polycythemia vera, a blood disease that causes the overproduction of red blood cells. Today, the U.S. Related Information.

FDA Approval 40

FDA Approval Gene Production Drugs 40

FDA Law Blog

MARCH 29, 2023

Richardson — Early on March 29, 2023, FDA announced the landmark approval of Narcan (naloxone hydrochloride) Nasal Spray for use as a nonprescription opioid overdose reversal agent. When OTC NNS will become commercially available is ultimately determined by the sponsor of the drug—Emergent BioSolutions.

Pharmacy 105

Pharmacy Drugs Manufacturing Production 105

XTalks

FEBRUARY 16, 2023

In 2022, Indorsia’s insomnia drug Quviviq (daridorexant) brought in a total of ₣6.5 Though the drug — which was launched in the US in May 2022 and in parts of Europe in November — wasn’t the focus of the disease-awareness campaign, Indorsia was using the campaign to establish its reputation in the sleep aid space.

FDA Approval 105

FDA Approval Sales Branding Drugs 105

XTalks

MAY 22, 2023

Allergan Aesthetics, an AbbVie company renowned for its development of leading aesthetics brands and products, recently announced the US Food and Drug Administration (FDA) approved their ground-breaking hyaluronic acid product, SkinVive by Juvéderm, for achieving remarkable skin smoothness.

Filler 92

Filler FDA Approval Dermatology In-Vivo 92

FDA Law Blog

JUNE 23, 2021

Valentine — For the last 13 years, this blogger has been at the center of what has now been dubbed “patient-focused drug development.” For 6 years, I served as a patient liaison within FDA in what was then called the Office of Special Health Issues. Patient Input in the Approval of Aduhelm: Setting the Context for Accelerated Approval.

FDA Approval 52

FDA Approval Drugs Development Clinical Trials 52

The Pharma Data

DECEMBER 13, 2020

Food and Drug Administration (FDA) approved a first-of-its-kind intentional genomic alteration (IGA) in a line of domestic pigs, referred to as GalSafe pigs, which may be used for food or human therapeutics. Food and Drug Administration. SILVER SPRING, Md. , 14, 2020 /PRNewswire/ — Today, the U.S.

FDA Approval 52

FDA Approval Genomics Genome Production 52

Roots Analysis

JANUARY 17, 2024

Renowned for psychiatric drugs such as Prozac, the company faced several challenges in revenue generation during the 2010s due to patent expiration of its innovative drugs. However, a strategic shift and a focus on innovative treatments have catapulted Eli Lilly to unprecedented heights, especially in the field of anti-obesity drugs.

Drugs 40

Drugs Cosmetics Marketing FDA Approval 40

XTalks

MARCH 13, 2024

As the stars lined up on Hollywood Boulevard for the Oscars on Sunday evening, Eli Lilly took the stage with a TV ad that took shots at Hollywood’s latest weight loss frenzy — GLP-1 drugs. Lilly said it doesn’t endorse use of the medications “outside of a medicine’s FDA-approved indication.”

Medicine 52

Medicine Cosmetics FDA Approval Drugs 52

FDA Law Blog

JANUARY 5, 2022

Sara’s practice covers the intersection of FDA regulatory issues and Intellectual Property, including the Hatch-Waxman Amendments, the Biologics Price Competition and Innovation Act, and the Orphan Drug Act, biosimilars, and the Orange Book. Sara joined the firm from a well-recognized intellectual property firm in 2017.

Cosmetics 40

Cosmetics FDA Approval Regulation Drugs 40

FDA Law Blog

JANUARY 4, 2024

This unique forum, designed for in-house counsel and executives, as well as private practice attorneys working for the OTC drug industry will provide invaluable insights on FDA’s most recent directives and compliance standards governing OTC drug production, marketing and distribution. Deb along with fellow panelists Kyle Y.

Compliance 52

Compliance Drugs Regulation FDA Approval 52

FDA Law Blog

JANUARY 18, 2024

Houck — In August 2023 the Food and Drug Administration (“FDA”) and Health and Human Services (“HHS”) recommended that the Drug Enforcement Administration (“DEA”) reschedule marijuana from schedule I under the federal Controlled Substances Act (“CSA”) to schedule III. The drug’s history and current pattern of abuse.

Drugs 69

Drugs FDA Approval Containment Cosmetics 69

FDA Law Blog

SEPTEMBER 6, 2023

Farquhar — A drug manufacturer’s bad post-inspection grade from the U.S. Food and Drug Administration – labeled an “Official Action Indicated” classification – is generally devastating for the facility, not least because it can stall FDA approval of applications to market drugs manufactured at the facility.

Generic Drugs 45

Generic Drugs Manufacturing Drugs Cosmetics 45

FDA Law Blog

OCTOBER 4, 2021

In yet another decision based on statutory interpretation, an appellate court has decided that FDA’s interpretation of the Federal Food, Drug, and Cosmetic Act (FDCA) is contrary to the plain text of the statute. As courts keep hitting the Agency “…Baby, One More Time ,” the appellate court these days seems Toxic for FDA.

Drugs 52

Drugs Marketing Production Cosmetics 52

The Pharma Data

APRIL 7, 2023

Food and Drug Administration announced the final decision to withdraw approval of Makena—a drug that had been approved under the accelerated approval pathway. This drug was approved to reduce the risk of preterm birth in women pregnant with one baby who have a history of spontaneous preterm birth.

Scientist 40

Scientist FDA Approval Cosmetics Production 40

FDA Law Blog

JULY 5, 2023

Palmer — Last week FDA published a long-awaited Draft Guidance for outsourcing facilities addressing the Prohibition on Wholesaling Under Section 503B of the Federal Food, Drug, and Cosmetic Act (Draft Guidance). See 21 U.S.C. 353b(a)(8). Section II at 2.

Drugs 52

Drugs Production Manufacturing Licensing 52

FDA Law Blog

AUGUST 16, 2021

Koblitz — Meet the newest category of drug applications: the PANDA. Nonetheless, FDA has been calling them ANDAs and listing them in the Orange Book as ANDAs for years, but recent changes to the Orange Book have spurred some confusion.

Production 52

Production Drugs Generic Drugs Cosmetics 52

Pharmacy Checkers

NOVEMBER 21, 2019

The Food and Drug Administration (FDA) is just one agency out of the many that make up the United States Department of Health and Human Services and, from PharmacyChecker’s relatively small (non-regulatory) role of helping verify online pharmacies to protect public health, I’ve learned just how insanely massive its mandate is.

Generic Drugs 68

Generic Drugs Manufacturing Drugs Regulation 68

The Pharma Data

NOVEMBER 20, 2020

Food and Drug Administration has scheduled a meeting of its Vaccines and Related Biological Products Advisory Committee (VRBPAC) on Dec. The FDA recognizes that transparency and dialogue are critical for the public to have confidence in COVID-19 vaccines. Source: FDA. BNT162b2 (SARS-CoV-2 vaccine) FDA Approval History.

Vaccination 52

Vaccination Vaccine Cosmetics Production 52

FDA Law Blog

MAY 3, 2021

for failure to submit the required information following completion of a clinical trial evaluating the safety and effectiveness of the drug dalantercept in combination with axitinib in patients with advanced renal cell carcinoma (see FDA press release announcing the Notice of Noncompliance here ). 42 C.F.R. §§ 11.10, 11.44(a).

Clinical Trials 52

Clinical Trials Clinical Trials Trials Regulation 52

The Pharma Data

MARCH 29, 2022

Food and Drug Administration authorized a second booster dose of either the Pfizer-BioNTech or the Moderna COVID-19 vaccines for older people and certain immunocompromised individuals. The FDA previously authorized a single booster dose for certain immunocompromised individuals following completion of a three-dose primary vaccination series.

Vaccination 52

Vaccination Vaccine FDA Approval Immune Response 52

FDA Law Blog

APRIL 21, 2024

Usually at this point in a post we would identify the date of approval of the relevant NDA. But that’s the controversy here: Did FDA approve LYTGOBI NDA 214801 on September 30, 2022 when the Agency issued its initial approval letter , or on October 5, 2022 when FDA issued a corrected approval letter ?

Production 59

Production Marketing FDA Approval Cosmetics 59

FDA Law Blog

FEBRUARY 29, 2024

As FDA explains on its website (which includes lists— here and here —of the more than 300 Accelerated Approvals (and withdrawals)): The FDA instituted its Accelerated Approval Program to allow for earlier approval of drugs that treat serious conditions, and fill an unmet medical need based on a surrogate endpoint.

Production 59

Production Drugs FDA Approval Compliance 59

The Pharma Data

DECEMBER 4, 2021

Continuing to advance and launch much-needed generic drugs is critical to ensuring access to quality medicines to everyone who needs them.” You are encouraged to report side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088. About Teva. Teva Pharmaceutical Industries Ltd.

Doctors 52

Doctors Doctor Medicine Production 52

The Pharma Data

FEBRUARY 13, 2022

Food and Drug Administration issued an emergency use authorization (EUA) for a new monoclonal antibody for the treatment of COVID-19 that retains activity against the omicron variant. director of the FDA’s Center for Drug Evaluation and Research. The issuance of an EUA is different than an FDA approval.

Antibody 40

Antibody Vaccination Vaccine FDA Approval 40

FDA Law Blog

MAY 3, 2021

for failure to submit the required information following completion of a clinical trial evaluating the safety and effectiveness of the drug dalantercept in combination with axitinib in patients with advanced renal cell carcinoma (see FDA press release announcing the Notice of Noncompliance here ). 42 C.F.R. §§ 11.10, 11.44(a).

Clinical Trials 40

Clinical Trials Clinical Trials Trials Regulation 40

The Pharma Data

DECEMBER 18, 2020

Action Follows Thorough Evaluation of Available Safety, Effectiveness, and Manufacturing Quality Information by FDA Career Scientists, Input from Independent Experts. Director of the FDA’s Center for Biologics Evaluation and Research. Food and Drug Administration. SILVER SPRING, Md. , SOURCE U.S. Source link.

Vaccination 52

Vaccination Vaccine Production Manufacturing 52